| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 13.62B | 13.15B | 13.71B | 15.69B | 16.34B | 16.09B |
| Gross Profit | 3.26B | 3.17B | 4.06B | 5.95B | 7.41B | 7.23B |
| EBITDA | 2.83B | 3.00B | 3.86B | 5.91B | 7.73B | 7.58B |
| Net Income | 1.82B | 1.79B | 5.12B | 3.26B | 3.11B | 4.13B |
Balance Sheet | ||||||
| Total Assets | 115.01B | 114.90B | 118.55B | 116.33B | 112.93B | 112.59B |
| Cash, Cash Equivalents and Short-Term Investments | 28.43B | 29.55B | 39.33B | 31.65B | 33.53B | 32.20B |
| Total Debt | 1.04B | 1.12B | 1.53B | 2.01B | 2.35B | 2.86B |
| Total Liabilities | 13.60B | 14.07B | 15.73B | 15.93B | 17.78B | 18.82B |
| Stockholders Equity | 100.80B | 100.23B | 102.23B | 99.84B | 94.56B | 93.11B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -1.01B | 1.56B | -746.00M | 2.88B | 1.96B |
| Operating Cash Flow | 0.00 | 442.00M | 2.81B | 921.00M | 5.14B | 3.72B |
| Investing Cash Flow | 0.00 | -5.32B | 7.23B | -1.51B | -2.29B | -1.46B |
| Financing Cash Flow | 0.00 | -4.96B | -2.36B | -1.29B | -1.52B | -2.52B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥85.64B | 9.39 | ― | 3.40% | -6.27% | -11.07% | |
71 Outperform | ¥82.56B | 17.43 | ― | 2.39% | 4.72% | 47.55% | |
70 Outperform | ¥51.79B | 28.22 | ― | 2.00% | 26.99% | -26.97% | |
70 Outperform | ¥22.98B | 6.17 | ― | 2.69% | -2.62% | -23.15% | |
67 Neutral | €28.13B | 10.52 | 5.90% | 3.77% | 3.04% | 44.65% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
64 Neutral | €75.62B | 40.96 | 1.87% | 1.20% | 6.40% | 230.12% |